Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Virginie Vannier-Moreau"'
Autor:
Raphaele Seror, Valérie Devauchelle-Pensec, Maxime Beydon, Laurent Chiche, Guillaume Desjeux, Joe Zhuo, Virginie Vannier-Moreau
Publikováno v:
RMD Open, Vol 10, Iss 1 (2024)
Objectives To estimate prevalence, incidence and mortality rates, and annual healthcare costs of primary Sjögren’s syndrome (pSS) and SS associated with other autoimmune disorders (SS+AID) in France.Methods French national healthcare claims-based
Externí odkaz:
https://doaj.org/article/01e867e1fafb4b9eaea4c766096d533c
Autor:
Arnaud Constantin, R.M. Flipo, Philippe Goupille, M. Chartier, Virginie Vannier-Moreau, Xavier Mariette
Publikováno v:
Revue du Rhumatisme. 87:A105-A106
Introduction ASCORE (Abatacept [ABA] SubCutaneOus in Routine clinical practicE ; ClinicalTrials.gov : NCT02090556 ) est une etude observationnelle internationale, sur 2 ans, conduite chez des patients atteints de PR moderee a severe pour qui un trait
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::417f383f9247299c2cd40313c987f152
https://doi.org/10.1016/j.rhum.2020.10.180
https://doi.org/10.1016/j.rhum.2020.10.180
Autor:
Pascal Hilliquin, Xavier Mariette, M. Chartier, Alain Cantagrel, Virginie Vannier-Moreau, Julia Heitzmann, Philippe Gaudin, Thierry Schaeverbeke
Publikováno v:
Joint Bone Spine
Joint Bone Spine, Elsevier Masson, 2019, 86, pp.753-759. ⟨10.1016/j.jbspin.2019.07.006⟩
Joint Bone Spine, Elsevier Masson, 2019, 86, pp.753-759. ⟨10.1016/j.jbspin.2019.07.006⟩
Abatacept retention rates were evaluated in the French cohort in the prospective ACTION study (2010-2013), which included patients with moderate-to-severe rheumatoid arthritis managed in everyday clinical practice and started on intravenous abatacept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c693b40e60d1fc822e92e7388ba2d7c
https://hal.archives-ouvertes.fr/hal-03489017/file/S1297319X19301125.pdf
https://hal.archives-ouvertes.fr/hal-03489017/file/S1297319X19301125.pdf
Autor:
Xavier Mariette, Julia Heitzmann, Pascal Hilliquin, Alain Cantagrel, Thierry Schaeverbeke, Philippe Gaudin, Virginie Vannier-Moreau, M. Chartier
Publikováno v:
Revue du Rhumatisme
Revue du Rhumatisme, Elsevier, 2019, 86, pp.483-489. ⟨10.1016/j.rhum.2019.06.009⟩
Revue du Rhumatisme, 2019, 86, pp.483-489. ⟨10.1016/j.rhum.2019.06.009⟩
Revue du Rhumatisme, Elsevier, 2019, 86, pp.483-489. ⟨10.1016/j.rhum.2019.06.009⟩
Revue du Rhumatisme, 2019, 86, pp.483-489. ⟨10.1016/j.rhum.2019.06.009⟩
Resume Objectifs La cohorte des patients francais inclus dans l’etude ACTION (2010–2013) a ete analysee. Cette etude en vie reelle, prospective, portait sur des patients atteints de polyarthrite rhumatoide moderee a severe, ayant initie un traite
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40f3d70935552a6c7566e9045b7cd19
https://hal.archives-ouvertes.fr/hal-03488971
https://hal.archives-ouvertes.fr/hal-03488971
Autor:
Bristol-Myers Squibb, Guido Hack, Laurent Fauchier, Cinira Lefevre, Matthew Lumley, Shuk-Li Collings, Virginie Vannier-Moreau, G. Stynes, David J. Evans, Andrew Maguire, Michelle D. Johnson
Publikováno v:
Journal of the American College of Cardiology. 69:498
Background: Discontinuation of oral anticoagulant (OAC) therapy in patients with non-valvular atrial fibrillation (NVAF) leaves patients unprotected from risk of stroke. We investigated OAC treatment persistence in NVAF in primary care of 3 European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dacba13feb48e1410f3c8ce02342ea29
https://doi.org/10.1016/s0735-1097(17)33887-1
https://doi.org/10.1016/s0735-1097(17)33887-1